Detalhe da pesquisa
1.
Two-year target vessel-related outcomes following use of off-the-shelf branched endografts for the treatment of thoracoabdominal aortic aneurysms.
J Vasc Surg
; 78(2): 289-298, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37044318
2.
Updated outcomes from the TRANSFIX study to evaluate endovascular repair of blunt thoracic aortic injuries with the Zenith Alpha thoracic device.
J Vasc Surg
; 71(6): 1851-1857, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32014287
3.
Endovascular repair for blunt thoracic aortic injury using the Zenith Alpha low-profile device.
J Vasc Surg
; 62(6): 1495-503.e1, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26391458
4.
Delayed-release oral mesalamine 4.8 g/day (800-mg tablet) is effective for patients with moderately active ulcerative colitis.
Gastroenterology
; 137(6): 1934-43.e1-3, 2009 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-19766640
5.
Delayed-release oral mesalamine at 4.8 g/day (800 mg tablet) for the treatment of moderately active ulcerative colitis: the ASCEND II trial.
Am J Gastroenterol
; 100(11): 2478-85, 2005 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-16279903